Lana E. Kandalaft Pharm.D, Ph.D, MTR

Dr. Kandalaft, along with faculty researchers at the Ovarian Cancer Research Center, is interested in moving the biologically-focused research ideas into clinical trials. Dr. Kandalaft plays an integral role in the development and implementation of these clinical protocols stemming from the laboratory discoveries of the OCRC and the Abramson Family Cancer Research Institute (AFCRI). Her role encompasses working with researches in the laboratory to finalize pre-clinical data required for IND submission, supervising the regulatory team and the clinical team to ensure compliance with FDA, IRB and CTSMRC regulations and coordinating with the business team, clinical team of nurses, sub investigators, clinical fellows and core directors to ensure a seamless clinical operation at the OCRC.